You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 23, 2025

Drug Price Trends for BUFFERED ASPIRIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for BUFFERED ASPIRIN

Average Pharmacy Cost for BUFFERED ASPIRIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
BUFFERED ASPIRIN 325 MG TB 70000-0147-01 0.02012 EACH 2025-05-21
BUFFERED ASPIRIN 325 MG TB 70000-0147-01 0.01982 EACH 2025-04-23
BUFFERED ASPIRIN 325 MG TB 70000-0147-01 0.01966 EACH 2025-03-19
BUFFERED ASPIRIN 325 MG TB 70000-0147-01 0.01940 EACH 2025-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Buffered Aspirin Market Analysis and Price Projections

Introduction to Buffered Aspirin

Buffered aspirin is a formulation of aspirin that includes a buffering agent, typically antacids like calcium carbonate or magnesium hydroxide, to reduce the gastrointestinal side effects associated with traditional aspirin. This formulation is particularly beneficial for individuals who experience stomach upset or ulcers when taking regular aspirin.

Global Aspirin Market Overview

The global aspirin market, which includes buffered aspirin, has been experiencing steady growth driven by several key factors.

Market Size and Growth

The aspirin market was valued at USD 2.47 billion in 2023 and is expected to grow to USD 2.59 billion in 2024, with a compound annual growth rate (CAGR) of 4.9%[4]. By 2030, the market is projected to reach USD 3.42 billion, growing at a CAGR of 4.62% from 2025 to 2030[5].

Drivers of Market Growth

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of heart attacks, strokes, and other cardiovascular diseases has increased the demand for aspirin as a preventive and therapeutic measure. Aspirin's role in reducing the risk of these conditions is a significant driver of market growth[2][4][5].

Technological Advancements in Drug Delivery Systems

Advancements in drug delivery systems have led to the development of aspirin formulations with controlled release, which can minimize gastrointestinal side effects and improve patient adherence. These innovations are contributing to the market's expansion[2].

Rising Geriatric Population

The global aging population is experiencing an increase in age-related illnesses such as cardiovascular disease and arthritis, for which aspirin is frequently prescribed. This demographic shift is driving the demand for aspirin and its buffered formulations[2][5].

Price Trends and Projections

Current Price Trends

In recent months, aspirin prices have seen significant fluctuations due to various factors.

  • United States: Aspirin prices surged to 3,300 USD/MT in September 2024, driven by strong demand and supply chain disruptions such as port congestion and transportation delays[1].
  • China: Prices fluctuated significantly, settling at 2,890 USD/MT in September 2024, influenced by seasonal demand changes and cost movements[1].
  • Germany: Aspirin prices rose sharply to 3,190 USD/MT in September 2024, driven by strong demand and supply chain issues, as well as broader economic factors like interest rate adjustments[1].

Factors Influencing Price Movements

Raw Material Costs

Fluctuations in the cost of raw materials used in aspirin production can significantly impact prices. Increases in these costs can lead to higher prices for the final product[1].

Production Fluctuations

Changes in production levels, whether due to capacity issues or supply chain disruptions, can affect the availability of aspirin and thus influence its price[1].

Geopolitical Influences

Global events and geopolitical tensions can impact shipping, transportation, and overall supply chain stability, leading to price volatility[1].

Inventory Management

Strategic inventory management by key market players can also influence price movements, as seen in the recent price surges in the North American and European markets[1].

Market Segmentation and Dynamics

Route of Administration

The oral route of administration dominates the aspirin market due to its convenience and the rising prevalence of cardiac disorders. Other routes, such as rectal and parenteral, also play significant roles but to a lesser extent[2].

Dosage Forms

Tablets, capsules, injections, and suppositories are the primary dosage forms. Buffered aspirin, particularly in tablet form, is popular due to its reduced gastrointestinal side effects[2].

Applications

Aspirin is used for pain, fever, and inflammation, as well as for preventing deep vein thrombosis and other cardiovascular conditions. Its anti-inflammatory properties and preventive benefits for stroke and heart attacks are key drivers of its market growth[2][4].

End Users

Hospitals, clinics, and other healthcare facilities are the primary end users of aspirin. The growing need for pain management and cardiovascular health in these settings contributes to the market's expansion[2].

Future Market Opportunities and Challenges

Opportunities

  • Research into Anticancer Properties: Emerging research on aspirin's potential anticancer properties and its application in managing dementia opens new therapeutic avenues and investment opportunities in R&D[5].
  • Telemedicine and Self-Care: The growing popularity of telemedicine and self-care practices is expected to increase the demand for aspirin, especially through online pharmacies[5].

Challenges

  • Gastrointestinal Side Effects: Despite the benefits of buffered aspirin, gastrointestinal side effects remain a challenge. The availability of alternative medications with improved efficacy and fewer side effects poses a market restraint[5].
  • Regulatory Constraints: Stringent regulatory requirements for the approval of new formulations and applications of aspirin can slow market growth and innovation[5].

Key Takeaways

  • The global aspirin market, including buffered aspirin, is expected to grow significantly due to increasing cardiovascular disease prevalence, technological advancements, and a rising geriatric population.
  • Price trends are influenced by raw material costs, production fluctuations, geopolitical influences, and inventory management strategies.
  • Market segmentation highlights the dominance of oral administration and the importance of various dosage forms and applications.
  • Future opportunities include R&D into new therapeutic uses and the growth of telemedicine, while challenges include gastrointestinal side effects and regulatory constraints.

FAQs

What are the primary drivers of the aspirin market growth?

The primary drivers include the increasing prevalence of cardiovascular diseases, technological advancements in drug delivery systems, and the rising geriatric population.

How is the global aspirin market expected to grow in the next few years?

The market is expected to grow from USD 2.47 billion in 2023 to USD 3.42 billion by 2030, with a CAGR of 4.62% from 2025 to 2030.

What are the key factors influencing aspirin prices?

Key factors include raw material costs, production fluctuations, geopolitical influences, and strategic inventory management by market players.

What are the main applications of aspirin?

Aspirin is used for pain, fever, and inflammation, as well as for preventing deep vein thrombosis and other cardiovascular conditions.

What challenges does the aspirin market face?

The market faces challenges such as gastrointestinal side effects, the availability of alternative medications, and stringent regulatory requirements.

Sources

  1. IMARC Group: "Analyzing Global Aspirin Prices Report, Latest Trend, Historical & Forecast Data"[1].
  2. Data Bridge Market Research: "Global Aspirin Market – Industry Trends and Forecast to 2030"[2].
  3. Verified Market Research: "In-Depth Industry Outlook: Aspirin Market Size & Forecast"[3].
  4. The Business Research Company: "Global Aspirin Market Report 2024"[4].
  5. GlobeNewswire: "The $3.42 Billion Aspirin Industry 2025-2030 - Emerging Opportunities in Aspirin's Anticancer and Dementia Research Drive Potential for R&D and Strategic Partnerships"[5].
Last updated: 2025-01-02

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.